An activity pattern in certain genes responsible for building proteins known as spleen tyrosine kinases can predict which melanoma patients are likely to have severe side effects from immunotherapy designed to treat the most deadly skin cancer, a new study shows.
2024
TCR CDR3s and renalase-1 linked to increased melanoma survival
A new research paper titled “Chemical complementarity of tumor resident, T-cell receptor CDR3s and renalase-1 correlates with increased melanoma survival" has been published in Oncotarget.
Cancer Vaccine for NSCLC and Melanoma Could Be Paradigm-Changing
The cancer vaccine, mRNA-4157, garnered immune responses of 30 weeks among some patients with melanoma and lung cancer, study results showed.
Free sunscreen offered at several popular Maine beaches as part of Harvard study
OLD ORCHARD BEACH, Maine — Approximately one person dies of melanoma every hour in the U.S., according to the American Cancer Society.